News

News

WIB_icon

Adding All-Trans Retinoic Acid to Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

A combination regimen comprising all-trans retinoic acid (ATRA) plus low-dose rituximab was associated with an 80% overall response rate and a 61% sustained response...
WIB_icon

Liso-Cel Shows Promising Safety and Efficacy in Relapsed/Refractory CLL/SLL

In patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), treatment with lisocabtagene maraleucel (liso-cel) was associated with deep, rapid responses...
WIB_icon

Comparing AHCT Versus CAR T-Cell Therapy in Relapsed DLBCL

Compared with chimeric antigen receptor (CAR) T-cell therapy, autologous hematopoietic cell transplantation (AHCT) led to a lower incidence of relapse and superior overall survival...
WIB_icon

How Long Is the Indolent Preclinical Phase of High-Risk CLL?

The indolent preclinical phase of chronic lymphocytic leukemia (CLL) may be longer than previously thought, with some high-risk subtypes of CLL occurring as many...
The Society Pages

ASH Remembers Joseph Bertino, National Academy of Medicine Elects Helen Heslop, and more

Remembering Joseph Bertino (1930 – 2021) Pioneering oncologist Joseph R. Bertino, MD, died on October 11, 2021, at the age of 91.In 1961, Dr. Bertino...
ASH Directions

ASH Congratulates Three New ASH Executive Committee Members, and more

Congratulations to Three New ASH Executive Committee Members! The American Society of Hematology (ASH) has announced the election of three new members to its Executive...
WIB_icon

POD24 Predicts Poor Prognosis in Follicular Lymphoma

Disease progression within 24 months of frontline chemoimmunotherapy (POD24) was highly predictive of poor prognosis in patients with follicular lymphoma (FL). In a study...
WIB_icon

Identifying Nosology of Splenic Marginal Zone B-Cell Lymphoma to Improve Targetable Therapy Development

A new study has identified a molecular-based nosology of splenic marginal zone B-cell lymphoma (SMZL) that researchers suggest could improve disease classification and aid...

Therapeutic Heparin May Benefit Moderately Ill, Hospitalized Patients With COVID-19

The use of therapeutic heparin in hospitalized patients with moderately severe COVID-19 and increased D-dimer did not reduce the risk of a composite of...

USPSTF Announces New Approach to Gender Inclusivity

The U.S. Preventive Services Task Force (USPSTF) published an article in the Journal of the American Medical Association (JAMA), providing an overview of its...
Advertisement

Current Issue

December 2021 Volume 7 Issue 15

This issue explores doctor deserts, celebrates the 50th anniversary of the National Cancer Act, and more.

Block title